|Articles|July 20, 2016
JSS Selects OmniComm TrialMaster EDC
OmniComm Systems announces a three-year agreement with Montreal-based CRO JSS Medical Research.
Advertisement
OmniComm Systems announces a three-year agreement with Montreal-based CRO JSS Medical Research. OmniComm’s TrialMaster platform will be used for the collection of data in numerous clinical trials across global investigative sites.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
ACT Brief: De-Identified RWE Gains Ground, HHS Funding Stabilizes Research, and US Finalizes WHO Exit
2
What 2026 Will Demand From Clinical Operations: Rethinking Efficiency, Access, and AI
3
ACT Brief: Decentralized Innovation Faces Reality, RWE Finds Its Lane, and Clinical Ops Reset for 2026
4
ESG as a Quality System: Practical Steps to Embed Sustainability Into Vendor Oversight
5